Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data

Despite increasing drug treatment options for metastatic castration‐resistant prostate cancer (mCRPC) patients, real‐world treatment data are lacking. We conducted retrospective analyses of commercial claims and electronic medical record (EMR) databases to understand how treatment patterns for mCRPC...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaig, Thomas W., Potluri, Ravi C., Ng, Yvette, Todd, Mary B., Mehra, Maneesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735776/
https://www.ncbi.nlm.nih.gov/pubmed/26710718
http://dx.doi.org/10.1002/cam4.576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735776/
https://www.ncbi.nlm.nih.gov/pubmed/26710718
http://dx.doi.org/10.1002/cam4.576

Ejemplares similares